Predictors and management of right heart failure after left ventricular assist device implantation

Nadia Fida, Matthias Loebe, Jerry D. Estep, Ashrith Guha

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Newer generation continuous-flow left ventricular assist devices (LVADs) have overall improved outcomes with lower incidences of right ventricular failure (RVF) than their pulsatile predecessors, yet RVF still occurs in 9% to 40% of LVAD recipients. Post-implant, RVF is associated with poor outcomes, end-organ dysfunction, high mortality, and reduced survival to transplant. Therefore, preoperative risk stratification, appropriate patient selection, and optimal timing of implant are of paramount importance. In this article, we review the definition, incidence, pathophysiology, and current risk prediction models for RVF and touch on the contemporary management of RVF perioperatively and post-LVAD implant.

Original languageEnglish (US)
Pages (from-to)18-23
Number of pages6
JournalMethodist DeBakey cardiovascular journal
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Heart-Assist Devices
Heart Failure
Incidence
Patient Selection
Transplants
Mortality

Keywords

  • cardiac risk factors
  • heart assist device
  • heart failure
  • outcomes
  • right heart dysfunction

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Predictors and management of right heart failure after left ventricular assist device implantation. / Fida, Nadia; Loebe, Matthias; Estep, Jerry D.; Guha, Ashrith.

In: Methodist DeBakey cardiovascular journal, Vol. 11, No. 1, 01.01.2015, p. 18-23.

Research output: Contribution to journalArticle

@article{bf0849a36a3d40ea88dd5ab7b599cbfa,
title = "Predictors and management of right heart failure after left ventricular assist device implantation",
abstract = "Newer generation continuous-flow left ventricular assist devices (LVADs) have overall improved outcomes with lower incidences of right ventricular failure (RVF) than their pulsatile predecessors, yet RVF still occurs in 9{\%} to 40{\%} of LVAD recipients. Post-implant, RVF is associated with poor outcomes, end-organ dysfunction, high mortality, and reduced survival to transplant. Therefore, preoperative risk stratification, appropriate patient selection, and optimal timing of implant are of paramount importance. In this article, we review the definition, incidence, pathophysiology, and current risk prediction models for RVF and touch on the contemporary management of RVF perioperatively and post-LVAD implant.",
keywords = "cardiac risk factors, heart assist device, heart failure, outcomes, right heart dysfunction",
author = "Nadia Fida and Matthias Loebe and Estep, {Jerry D.} and Ashrith Guha",
year = "2015",
month = "1",
day = "1",
doi = "10.14797/mdcj-11-1-18",
language = "English (US)",
volume = "11",
pages = "18--23",
journal = "Methodist DeBakey cardiovascular journal",
issn = "1947-6094",
publisher = "Methodist DeBakey Heart & Vascular Center",
number = "1",

}

TY - JOUR

T1 - Predictors and management of right heart failure after left ventricular assist device implantation

AU - Fida, Nadia

AU - Loebe, Matthias

AU - Estep, Jerry D.

AU - Guha, Ashrith

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Newer generation continuous-flow left ventricular assist devices (LVADs) have overall improved outcomes with lower incidences of right ventricular failure (RVF) than their pulsatile predecessors, yet RVF still occurs in 9% to 40% of LVAD recipients. Post-implant, RVF is associated with poor outcomes, end-organ dysfunction, high mortality, and reduced survival to transplant. Therefore, preoperative risk stratification, appropriate patient selection, and optimal timing of implant are of paramount importance. In this article, we review the definition, incidence, pathophysiology, and current risk prediction models for RVF and touch on the contemporary management of RVF perioperatively and post-LVAD implant.

AB - Newer generation continuous-flow left ventricular assist devices (LVADs) have overall improved outcomes with lower incidences of right ventricular failure (RVF) than their pulsatile predecessors, yet RVF still occurs in 9% to 40% of LVAD recipients. Post-implant, RVF is associated with poor outcomes, end-organ dysfunction, high mortality, and reduced survival to transplant. Therefore, preoperative risk stratification, appropriate patient selection, and optimal timing of implant are of paramount importance. In this article, we review the definition, incidence, pathophysiology, and current risk prediction models for RVF and touch on the contemporary management of RVF perioperatively and post-LVAD implant.

KW - cardiac risk factors

KW - heart assist device

KW - heart failure

KW - outcomes

KW - right heart dysfunction

UR - http://www.scopus.com/inward/record.url?scp=84930918269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930918269&partnerID=8YFLogxK

U2 - 10.14797/mdcj-11-1-18

DO - 10.14797/mdcj-11-1-18

M3 - Article

C2 - 25793025

AN - SCOPUS:84930918269

VL - 11

SP - 18

EP - 23

JO - Methodist DeBakey cardiovascular journal

JF - Methodist DeBakey cardiovascular journal

SN - 1947-6094

IS - 1

ER -